| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness KS Corbett, DK Edwards, SR Leist, OM Abiona, S Boyoglu-Barnum, ... Nature 586 (7830), 567-571, 2020 | 1540 | 2020 |
| Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates KS Corbett, B Flynn, KE Foulds, JR Francica, S Boyoglu-Barnum, ... New England Journal of Medicine 383 (16), 1544-1555, 2020 | 1194 | 2020 |
| Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen J Pallesen, N Wang, KS Corbett, D Wrapp, RN Kirchdoerfer, HL Turner, ... Proceedings of the National Academy of Sciences 114 (35), E7348-E7357, 2017 | 1123 | 2017 |
| Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies M Kanekiyo, CJ Wei, HM Yassine, PM McTamney, JC Boyington, ... Nature 499 (7456), 102-106, 2013 | 882 | 2013 |
| p53 inhibition by the LANA protein of KSHV protects against cell death J Friborg Jr, W Kong, MO Hottiger, GJ Nabel Nature 402 (6764), 889-894, 1999 | 865 | 1999 |
| A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice Z Yang, W Kong, Y Huang, A Roberts, BR Murphy, K Subbarao, GJ Nabel Nature 428 (6982), 561-564, 2004 | 843 | 2004 |
| Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection HM Yassine, JC Boyington, PM McTamney, CJ Wei, M Kanekiyo, ... Nature medicine 21 (9), 1065-1070, 2015 | 674 | 2015 |
| pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN ZY Yang, Y Huang, L Ganesh, K Leung, WP Kong, O Schwartz, ... Journal of virology 78 (11), 5642-5650, 2004 | 611 | 2004 |
| A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection W Akahata, ZY Yang, H Andersen, S Sun, HA Holdaway, WP Kong, ... Nature medicine 16 (3), 334-338, 2010 | 581 | 2010 |
| Induction of broadly neutralizing H1N1 influenza antibodies by vaccination CJ Wei, JC Boyington, PM McTamney, WP Kong, MB Pearce, L Xu, ... Science 329 (5995), 1060-1064, 2010 | 444 | 2010 |
| Rapid development of a DNA vaccine for Zika virus KA Dowd, SY Ko, KM Morabito, ES Yang, RS Pelc, CR DeMaso, ... Science 354 (6309), 237-240, 2016 | 428 | 2016 |
| Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein SL Epstein, W Kong, JA Misplon, CY Lo, TM Tumpey, L Xu, GJ Nabel Vaccine 23 (46-47), 5404-5410, 2005 | 387 | 2005 |
| Evaluation of candidate vaccine approaches for MERS-CoV L Wang, W Shi, MG Joyce, K Modjarrad, Y Zhang, K Leung, CR Lees, ... Nature communications 6 (1), 7712, 2015 | 341 | 2015 |
| Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination J Lee, DR Boutz, V Chromikova, MG Joyce, C Vollmers, K Leung, ... Nature medicine 22 (12), 1456-1464, 2016 | 319 | 2016 |
| Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ... Cell 166 (3), 609-623, 2016 | 319 | 2016 |
| Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses Z Yang, HC Werner, W Kong, K Leung, E Traggiai, A Lanzavecchia, ... Proceedings of the National Academy of Sciences 102 (3), 797-801, 2005 | 303 | 2005 |
| Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity ZY Yang, CJ Wei, WP Kong, L Wu, L Xu, DF Smith, GJ Nabel Science 317 (5839), 825-828, 2007 | 297 | 2007 |
| Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design CJ Wei, JC Boyington, K Dai, KV Houser, MB Pearce, WP Kong, Z Yang, ... Science translational medicine 2 (24), 24ra21-24ra21, 2010 | 295 | 2010 |
| Overcoming immunity to a viral vaccine by DNA priming before vector boosting Z Yang, LS Wyatt, W Kong, Z Moodie, B Moss, GJ Nabel Journal of virology 77 (1), 799-803, 2003 | 267 | 2003 |
| Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor A Pegu, Z Yang, JC Boyington, L Wu, SY Ko, SD Schmidt, K McKee, ... Science translational medicine 6 (243), 243ra88-243ra88, 2014 | 254 | 2014 |
